Gecacitinib for cGVHD: Safety and Efficacy in Patients After ≥2 Lines of Prior Therapy

Clinical trial NCT07012304 · RECRUITING

Trial details

NCT number: NCT07012304
Sponsor: Yujun DONG
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Graft Versus Host Disease

Start date: 2025-06-30
Primary completion: 2027-02-28
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.